https://www.fda.gov/media/143557/download
Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation Individuals using assistive technology may not be able to fully access the information contained in this file. For assistance, please send an e-mail to:
ocod@fda.hhs.gov and include 508 Accommodation and the title of the document in the subject line of your email.
FDA Safety Surveillance of COVID-19 Vaccines : DRAFT Working list of possible adverse event outcomes ***Subject to change***
Guillain-Barré syndrome
Acute disseminated encephalomyelitis
Transverse myelitis
Encephalitis/myelitis/encephalomyelitis/ meningoencephalitis/meningitis/ encepholapathy
Convulsions/seizures
Stroke
Narcolepsy and cataplexy
Anaphylaxis
Acute myocardial infarction
Myocarditis/pericarditis
Autoimmune disease
Deaths
Pregnancy and birth outcomes
Other acute demyelinating diseases
Non-anaphylactic allergic reactions
Thrombocytopenia
Disseminated intravascular coagulation
Venous thromboembolism
Arthritis and arthralgia/joint pain
Kawasaki disease
Multisystem Inflammatory Syndrome in Children
Vaccine enhanced disease